tradingkey.logo
搜尋

Baxter International Inc

BAX
添加自選
21.550USD
+0.510+2.42%
收盤 06/25, 16:00美東報價延遲15分鐘
11.13B總市值
虧損本益比TTM

關於 Baxter International Inc 公司

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Baxter International Inc簡介

公司代碼BAX
公司名稱Baxter International Inc
上市日期Jun 20, 2097
CEOHider (Andrew P)
員工數量38000
證券類型Ordinary Share
年結日Jun 20
公司地址One Baxter Parkway
城市DEERFIELD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編60015
電話12249482000
網址https://www.baxter.com/
公司代碼BAX
上市日期Jun 20, 2097
CEOHider (Andrew P)

Baxter International Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
28.89K
+44.43%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
23.66K
+54.26%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
20.92K
+61.36%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%

常見問題

Baxter International Inc的前五大股東是誰?

Baxter International Inc的前五大股東如下:Mr. Andrew P. Hider

有多少機構持有Baxter International Inc(BAX)的股份?

截至2026Q1,共有1767家機構持有Baxter International Inc的股份,合計持有的股份價值約為557.84M,占公司總股份的108.01% 。與2025Q4相比,機構持股有所增加,增幅為-45350754.00。

哪個業務部門對Baxter International Inc的收入貢獻最大?

在2026Q1,Infusion Therapies and Technologies業務部門對Baxter International Inc的收入貢獻最大,創收4.10B,占總收入的36.47% 。
KeyAI